Zealand Pharma A/S
CSE:ZEAL
Zealand Pharma A/S
CSE:ZEAL
Price:
294.4
DKK
6.32%
Market Closed
Market Cap:
kr21.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zealand Pharma A/S
CSE:ZEAL
|
DK |
|
Vale SA
NYSE:VALE
|
BR |
|
C
|
Carrefour SA
BMV:CAN
|
FR |
|
M
|
Marsh & McLennan Companies Inc
XETRA:MSN
|
US |
|
Federal International (2000) Ltd
SGX:BDU
|
SG |
|
H
|
Hygieia Group Ltd
HKEX:1650
|
SG |
Multiples-Based Value
The Multiples-Based Value of one
ZEAL
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 294.4 DKK,
Zealand Pharma A/S
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZEAL Multiples-Based Value
LOCKED
Multiples Across Competitors
ZEAL Competitors Multiples
Zealand Pharma A/S Competitors
Zealand Pharma A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Zealand Pharma A/S
CSE:ZEAL
|
19.6B DKK | 2.3 | 3.2 | 0.9 | 0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6.1 | 89.6 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 6 | 20.6 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.4 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41B EUR | 11.7 | 37.5 | 40.8 | 41.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
